Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma. The gene discussed is ZDHHC4; the disease is ovarian carcinoma.